Read the full article here.
This content was originally published by MarketWatch.com - Top Stories. Original publishers retain all rights. It appears here for a limited time before automated archiving. By MarketWatch.com - Top Stories
Eastman Kodak Co.’s share price rally after news of a $765 million government loan to help it make drug ingredients at its U.S. factories has offered shareholders and executives with stock options a tidy windfall. But they’re not alone.